Cargando…
Depression research: where are we now?
Extensive studies have led to a variety of hypotheses for the molecular basis of depression and related mood disorders, but a definite pathogenic mechanism has yet to be defined. The monoamine hypothesis, in conjunction with the efficacy of antidepressants targeting monoamine systems, has long been...
Autores principales: | Lee, Saebom, Jeong, Jaehoon, Kwak, Yongdo, Park, Sang Ki |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848031/ https://www.ncbi.nlm.nih.gov/pubmed/20219105 http://dx.doi.org/10.1186/1756-6606-3-8 |
Ejemplares similares
-
Valproate Alters Dopamine Signaling in Association with Induction of Par-4 Protein Expression
por: Lee, Saebom, et al.
Publicado: (2012) -
Correction: Valproate Alters Dopamine Signaling in Association with Induction of Par-4 Protein Expression
por: Lee, Saebom, et al.
Publicado: (2014) -
Onchodermatitis: Where Are We Now?
por: Murdoch, Michele E.
Publicado: (2018) -
Chemoquiescence for Ideal Cancer Treatment and Prevention: Where Are We Now?
por: Kangwan, Napapan, et al.
Publicado: (2014) -
Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023)